Arcus Biosciences Announces New Employment Inducement Grants

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 26, 2024

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions • Crescent Point at Niantic Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Third St • L.A. Care and Blue Shield of California Promise Health Plans Celebrate New Community Resource Center in West Los Angeles, Highli • Chestnut Park at Cleveland Circle Assisted Living Community Named One of the Country's Best by U.S. News & World Report • Books-A-Million Launches Its 22nd Coffee for the Troops Donation Campaign • 29 London Partners With US Media Company Bobi Media to Strengthen Market Offering • C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity™ Blood Testing for Alzheimer&rs • Suzano 2023 annual report on Form 20-F • Badger Meter Declares Regular Quarterly Dividend • Whitman-Walker Institute Applauds the Biden-Harris Administration for Finalizing Robust Affordable Care Act Nondiscrimination Pr • Levy Konigsberg Files Lawsuits on Behalf of 25 Men Who Allege They Were Sexually Abused as Juveniles Across Four New Jersey Juve • Carbon Removal and Mariculture Legislation Moves Forward in California Assembly • Harbor Point at Centerville Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Third • US Marine Corps Veteran to Celebrate Grand Opening of JDog Junk Removal & Hauling in Findlay on May 4th • Chase Opens Innovative Branch in Bronx’s Grand Concourse Neighborhood • CareTrust REIT Sets First Quarter Earnings Call for Friday, May 3, 2024 • Brothers to Host Grand Opening Event for JDog Junk Removal & Hauling Business on April 28th • Broadstone Net Lease Issues 2023 Sustainability Report • Getting Tattooed with Gay History • The Sallie Mae Fund Grants $75,000 to DC College Access Program to Support Higher Education Access and Completion

Arcus Biosciences Announces New Employment Inducement Grants

HAYWARD, Calif. , November 24 /Businesswire/ - Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensation Committee of the Company’s Board of Directors granted seven new employees options to purchase a total of 11,400 shares of the Company’s common stock at an exercise price per share of $27.17, which was the closing price on November 23, 2022, and restricted stock units to acquire a total of 5,700 shares of the Company’s common stock. The equity awards were granted pursuant to the Company’s 2020 Inducement Plan, which was approved by the Company’s Board of Directors in January 2020 pursuant to the “inducement exception” under NYSE Listed Company Manual Rule 303A.08.

About Arcus Biosciences

Arcus Biosciences is a clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines for people with cancer. In partnership with industry partners, patients and physicians around the world, Arcus is expediting the development of first- or best-in-class medicines against well characterized biology and pathways and studying novel, biology-driven combinations that have the potential to help people with cancer live longer. Founded in 2015, the company has expedited the development of six investigational medicines into clinical studies, including new combination approaches that target TIGIT, PD-1, the adenosine axis (CD73 and dual A2a/A2b) and most recently, HIF-2alfa. For more information about Arcus Biosciences’ clinical and pre-clinical programs, please visit www.arcusbio.com or follow us on Twitter.

Inducement PR

Source: Arcus Biosciences